FDA Panels Vote to Add Aspirin Warning to Naproxen Label FDA Panels Vote to Add Aspirin Warning to Naproxen Label

Two FDA panels voted to include a warning against concomitant aspirin use on the naproxen nonprescription Drug Facts label, and to make no such changes to the current ibuprofen label.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news